NASDAQ | ETF
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies.
A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.90% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 5.42% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 5.14% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.04% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.93% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.56% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.17% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.95% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.26% |
| UCB | UCB SA | Healthcare | Biotechnology | 3.21% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.12% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.81% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 2.62% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.48% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 2.38% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.24% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 2.24% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.10% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.01% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 1.96% |